Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 12/20 | 0.52 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11128969 | 1.00 | SIGMAR1 (0.52) | SIGMAR1MAOAMAPTRXFP1MAOB | |
| SCHEMBL3939372 | 1.00 | SIGMAR1 (0.52) | SIGMAR1MAOAMAPTRXFP1MAOB | |
| SCHEMBL542369 | 1.00 | SIGMAR1 (0.52) | SIGMAR1MAOAMAPTRXFP1MAOB | |
| SCHEMBL17558060 | 1.00 | SIGMAR1 (0.52) | SIGMAR1MAOAMAPTRXFP1MAOB | |
| SCHEMBL8735183 | 1.00 | SIGMAR1 (0.52) | SIGMAR1MAOAMAPTRXFP1MAOB | |
| SCHEMBL1144123 | 0.98 | MAOA (0.52) | SIGMAR1MAOAMAPTRXFP1MAOB | |
| SCHEMBL542843 | 0.91 | SIGMAR1 (0.48) | SIGMAR1MAOAMAOBL3MBTL1 | |
| SCHEMBL9825321 | 0.82 | SIGMAR1 (0.56) | SIGMAR1MAOAMAPTRXFP1MAOB | |
| SCHEMBL542482 | 0.81 | ALDH1A1 (0.48) | SIGMAR1MAOAMAOB | |
| SCHEMBL6546948 | 0.81 | SIGMAR1 (0.71) | SIGMAR1MAOAMAPTRXFP1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0586418-A1 | SUBSTITUTED TRIAZOLINONES | BAYER AG (DE) | 1994-03-16 | — | — | EP | claimed |
| US-5276008-A | Herbicides and plant growth regulators | BAYER AKTIENGESELLSCHAFT (DE) | 1994-01-04 | — | — | US | claimed |
| WO-1992020663-A1 | SUBSTITUTED TRIAZOLINONES | BAYER AKTIENGESELLSCHAFT (DE) | 1992-11-26 | — | — | WO | claimed |
| EP-0502307-A2 | Substituted 4,5-diamino-1,2,4-triazol-3-(thi)ones | BAYER AG (DE) | 1992-09-09 | — | — | EP | claimed |
| CN-101970559-B | Additive mixture for styrene polymers | BASF SE | 2014-03-05 | — | — | CN | disclosed |
| US-8569405-B2 | Additive mixtures for styrenic polymers | BASF SE (DE) | 2013-10-29 | — | — | US | disclosed |
| EP-2046147-B1 | METHOD OF USING ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2013-05-01 | — | — | EP | disclosed |
| EP-2238199-B1 | ADDITIVE MIXTURES FOR STYRENIC POLYMERS | BASF SE (DE) | 2011-08-31 | — | — | EP | disclosed |
| US-20110087034-A1 | Organic Semiconductor Material | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2011-04-14 | — | — | US | disclosed |
| US-20110046278-A1 | ADDITIVE MIXTURES FOR STYRENIC POLYMERS | BASF SE (US) | 2011-02-24 | — | — | US | disclosed |
| CN-101970559-A | Additive mixture for styrene polymers | BASF SE | 2011-02-09 | — | — | CN | disclosed |
| EP-2248818-A1 | ORGANIC SEMICONDUCTOR MATERIAL | Sumitomo Chemical Company, Limited (JP) | 2010-11-10 | — | — | EP | disclosed |
| EP-0498680-A1 | New beta-amino-alpha-hydroxycarboxylic acids and their use | Sankyo Company Limited (JP) | 1992-08-12 | — | — | EP | disclosed |
| EP-0349681-A1 | Methods for treating hydrocarbon recovery operations and industrial waters | PETROLITE CORPORATION (US) | 1990-01-10 | — | — | EP | disclosed |
| US-4864075-A | Dithiocarbamates for treating hydrocarbon recovery operations and industrial waters | PETROLITE CORPORATION (US) | 1989-09-05 | — | — | US | disclosed |
| US-3987087-A | ANTI-ULCER, NASAL PATENCY, WOUND HEALING, LABOR INDUCEMENT | THE UPJOHN COMPANY (US) | 1976-10-19 | — | — | US | disclosed |
| US-3983158-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-09-28 | — | — | US | disclosed |
| US-3983157-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-09-28 | — | — | US | disclosed |
| US-3980694-A | ANTIULCER, ANTIAGGLOMERANTS, INCREASE OF NASAL PATENCY, LABOR INDUCEMENT, WOUND HEALINGPROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-09-14 | — | — | US | disclosed |
| US-3931289-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | OR10J3, TST, OR51E2 | SIGMAR1 223/4885MAOA 2701/4885MAPT 3838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.